Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IST:GENIL.E
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| TR |
|
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IST:GENIL.E
|
36.5B TRY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.8B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
282B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.1B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
225.6B CHF |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
98B EUR |
Loading...
|
Market Distribution
| Min | -37 265.7% |
| 30th Percentile | -3.7% |
| Median | 1.9% |
| 70th Percentile | 11.9% |
| Max | 2 369% |
Other Profitability Ratios
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Glance View
Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS operates as a supplier of orphan drugs. The firm operates in the fields of manufacturing all kinds of pharmaceuticals for human use and health products, trading, import and export. Gen Ilac manufactures products used in the treatment of rare diseases and disorders in neurology, endocrinology, nephrology, oncology, hematology and pediatric branches. The firm has approximately 500 employees working in its production facilities on a closed area of 15,000 square meters, established on an area of approximately 43,000 square meters in Ankara ASO 2nd and 3rd Organized Industrial Zone. Entity has 5 offices abroad: Germany, Russia, Kazakhstan, Uzbekistan and Azerbaijan.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is 1.6%, which is below its 3-year median of 6.6%.
Over the last 3 years, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS’s Net Margin has decreased from 13.5% to 1.6%. During this period, it reached a low of 0.1% on Sep 30, 2024 and a high of 19.7% on Mar 31, 2023.
